173 related articles for article (PubMed ID: 20223725)
1. The 51st annual meeting of the American Society of Hematology.
Cunningham S; Muneer S; Ranganathan A; Shrader M
Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):11-20. PubMed ID: 20223725
[No Abstract] [Full Text] [Related]
2. [Hematological malignancies].
Usui N
Gan To Kagaku Ryoho; 2007 Mar; 34(3):358-66. PubMed ID: 17353625
[TBL] [Abstract][Full Text] [Related]
3. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy.
Decker M; Rothermundt C; Holländer G; Tichelli A; Rochlitz C
Lancet Oncol; 2006 Aug; 7(8):693-4. PubMed ID: 16887487
[No Abstract] [Full Text] [Related]
4. Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines.
Czuczman MS
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-46-52. PubMed ID: 23570100
[No Abstract] [Full Text] [Related]
5. Fourth biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Hülsewede H; Bohlius J; Engert A
J Natl Cancer Inst; 2006 Apr; 98(8):E1. PubMed ID: 16622111
[No Abstract] [Full Text] [Related]
6. [The standard treatments for patients with hematological malignancies in Japan].
Ishizawa K
Gan To Kagaku Ryoho; 2007 May; 34(5):709-12. PubMed ID: 17496442
[TBL] [Abstract][Full Text] [Related]
7. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
[TBL] [Abstract][Full Text] [Related]
8. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Fabbri A; Gozzetti A; Rigacci L
Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
[No Abstract] [Full Text] [Related]
9. Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Rancea M; Will A; Borchmann P; Monsef I; Engert A; Skoetz N
J Natl Cancer Inst; 2013 Aug; 105(15):1159-70. PubMed ID: 23852951
[TBL] [Abstract][Full Text] [Related]
10. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary.
Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H
Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380
[No Abstract] [Full Text] [Related]
11. Disseminated diffuse large B cell lymphoma of bone on PET scan.
Chen WL; Ho CL
Int J Hematol; 2008 Jul; 88(1):1-2. PubMed ID: 18478313
[No Abstract] [Full Text] [Related]
12. [Management of diffuse large B-cell lymphoma in the rituximab era].
Kinoshita T
Rinsho Ketsueki; 2009 Oct; 50(10):1342-50. PubMed ID: 19915341
[No Abstract] [Full Text] [Related]
13. Primary anaplastic large B-cell lymphoma in mandible: Long-term complete remission with R-CHOP regimen and involved field radiotherapy.
Niscola P; Palombi M; Trawinska MM; Scaramucci L; Giovannini M; Perrotti AP; Fabritiis Pd; Fratoni S
Oral Oncol; 2009 Sep; 45(9):e113. PubMed ID: 19457710
[No Abstract] [Full Text] [Related]
14. Primary mediastinal large B-cell lymphoma.
Faris JE; LaCasce AS
Clin Adv Hematol Oncol; 2009 Feb; 7(2):125-33. PubMed ID: 19367254
[TBL] [Abstract][Full Text] [Related]
15. 6th European Hematology Association Meeting. Frankfurt, Germany. June 21-24, 2001.
Maung K; D'Orazio AI
Clin Lymphoma; 2001 Sep; 2(2):74-9. PubMed ID: 11712544
[No Abstract] [Full Text] [Related]
16. [Occipital neuralgia (Arnold) as the presenting symptom of diffuse large B-cell non-Hodgkin lymphoma].
Bruneau O; Le Moigne F; Guyotat J; Nicolas-Virelizier E; Guilloton L; Drouet A
Rev Neurol (Paris); 2013 Feb; 169(2):175-8. PubMed ID: 23079854
[No Abstract] [Full Text] [Related]
17. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
[No Abstract] [Full Text] [Related]
18. A 61-year-old man with dyspepsia and weight loss.
Burton C
PLoS Med; 2005 Jun; 2(6):e154. PubMed ID: 15971937
[TBL] [Abstract][Full Text] [Related]
19. What constitutes "improved prognosis"?
Canellos GP
J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
[No Abstract] [Full Text] [Related]
20. Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Hainsworth JD; Flinn IW; Spigel DR; Clark BL; Griner PL; Vazquez ER; Doss HH; Shipley D; Franco LA; Burris HA; Greco FA;
Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):44-50. PubMed ID: 20223728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
